Pavol Joppa

Dr. Pavol Joppa


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
PJPavol Joppa
Pavol Joppa
RTRuzena Tkacova
Ruzena Tkacova
FFFrits M.E. Franssen
Frits M.E. Franssen
CHCorrine Hanson
Corrine Hanson
SRStephen I. Rennard
Stephen I. Rennard
ERErica P.A. Rutten
Erica P.A. Rutten

1 March 2005 in Wiener klinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
RTRužena Tkáčová
Ružena Tkáčová
PJPavol Joppa
Pavol Joppa
BSBranislav Stančák
Branislav Stančák
JŠJán Šalagovič
Ján Šalagovič
SMSilvia Mišíková
Silvia Mišíková
IKIvan Kalina
Ivan Kalina

31 October 2022 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
AYAshraf Yassen
Ashraf Yassen
KCKatrin Coeboeken
Katrin Coeboeken
Sébastien BaillySébastien Bailly
Sébastien Bailly
RBRolf Burghaus
Rolf Burghaus
JBJitka Buskova
Jitka Buskova
LGLudger Grote
Ludger Grote
Introduction: The European Sleep Apnea Database was used to identify distinguishable obstructive sleep apnoea (OSA) phenotypes and to investigate the clinical outcome during positive airway pressure (PAP) treatment.Method: Prospective OSA patient data were recruited from 35 sleep clinics in 21 European countries. Unsupervised cluster analysis (anthropometrics, clinical variables) was performed in a random sample (n=5000). Subsequently, all patients were assigned to the clusters using a conditional inference tree classifier. Responses to PAP treatment change in apnoea severity and Epworth sleepiness scale (ESS) were assessed in relation to baseline patient clusters and at short- and long-term follow-up.Results: At baseline, 20 164 patients were assigned (mean age 54.1±12.2 years, 73% male, median apnoea–hypopnoea index (AHI) 27.3 (interquartile range (IQR) 14.1–49.3) events·h−1, and ESS 9.8±5.3) to seven distinct clusters based on anthropometrics, comorbidities and symptoms. At PAP follow-up (median 210 [IQR 134–465] days), the observed AHI reduction (n=1075) was similar, whereas the ESS response (n=3938) varied: largest reduction in cluster 3 (young healthy symptomatic males) and 6 (symptomatic males with psychiatric disorders, −5.0 and −5.1 units, respectively (all p<0.01), limited reduction in clusters 2 (obese males with systemic hypertension) and 5 (elderly multimorbid obese males, −4.2 (p<0.05) and −3.7 (p<0.001), respectively). Residual sleepiness in cluster 5 was particularly evident at long-term follow-up (p<0.05).Conclusion: OSA patients can be classified into clusters based on clinically identifiable features. Importantly, these clusters may be useful for prediction of both short- and long-term responses to PAP intervention.

1 April 2014 in Respiratory Medicine
Verified
Journal Article
Closed access
PPPavol Pobeha
Pavol Pobeha
DPDarina Petrasova
Darina Petrasova
RTRuzena Tkacova
Ruzena Tkacova
PJPavol Joppa
Pavol Joppa

1 October 2009
Verified
Journal Article
Closed access
PSPeter Skyba
Peter Skyba
ZKZuzana Kluchova
Zuzana Kluchova
PJPavol Joppa
Pavol Joppa
DPDarina Petrasova
Darina Petrasova
RTRuzena Tkacova
Ruzena Tkacova